TP 53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients
Open Access
- 15 August 2011
- journal article
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 6 (1) , 13
Abstract
Background: Single-nucleotide polymorphisms within TP 53 gene (codon 72 exon 4, rs1042522, encoding either arginine or proline) and MDM2 promoter (SNP309; rs2279744), have been independently associated with increased risk of several cancer types. Few studies have analysed the role of these polymorphisms in the development of hepatocellular carcinoma. Methods: Genotype distribution of TP 53 codon 72 and MDM2 SNP309 in 61 viral hepatitis-related hepatocellular carcinoma cases and 122 blood samples (healthy controls) from Italian subjects were determined by PCR and restriction fragment length polymorphism (RFLP). Results: Frequencies of TP 53 codon 72 alleles were not significantly different between cases and controls. A significant increase of MDM2 SNP309 G/G and T/G genotypes were observed among hepatocellular carcinoma cases (Odds Ratio, OR = 3.56, 95% Confidence Limits, 95% CI = 1.3-9.7; and OR = 2.82, 95% CI = 1.3-6.4, respectively). Conclusions: These results highlight a significant role of MDM2 SNP309 G allele as a susceptibility gene for the development of viral hepatitis-related hepatocellular carcinoma among Italian subjects.Keywords
This publication has 47 references indexed in Scilit:
- Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic reviewJournal of Cancer Research and Clinical Oncology, 2011
- p53 codon 72 polymorphism and liver cancer susceptibility: A meta-analysis of epidemiologic studiesWorld Journal of Gastroenterology, 2011
- Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta‐analysisInternational Journal of Cancer, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Polymorphisms in p53 and the p53 pathway: roles in cancer susceptibility and response to treatmentJournal of Cellular and Molecular Medicine, 2009
- MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: A case–control analysis in a Moroccan populationCancer Detection Prevention, 2009
- Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancerEuropean Journal of Cancer, 2008
- The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan populationHepatology Research, 2007
- The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li–Fraumeni syndrome and related phenotypesEuropean Journal of Human Genetics, 2006
- A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in HumansCell, 2004